- Home
- IRON vs TCBK Comparison
IRON vs TCBK Comparison
Compare IRON & TCBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IRON
- TCBK
- Stock Information
- Founded
- IRON 2017
- TCBK 1975
- Country
- IRON United States
- TCBK United States
- Employees
- IRON N/A
- TCBK 1201
- Industry
- IRON Biotechnology: Pharmaceutical Preparations
- TCBK Major Banks
- Sector
- IRON Health Care
- TCBK Finance
- Exchange
- IRON Nasdaq
- TCBK Nasdaq
- Market Cap
- IRON 1.4B
- TCBK 1.3B
- IPO Year
- IRON N/A
- TCBK N/A
- Fundamental
- Price
- IRON $46.68
- TCBK $39.90
- Analyst Decision
- IRON Strong Buy
- TCBK Buy
- Analyst Count
- IRON 9
- TCBK 6
- Target Price
- IRON $93.89
- TCBK $47.80
- AVG Volume (30 Days)
- IRON 354.8K
- TCBK 87.2K
- Earning Date
- IRON 05-07-2025
- TCBK 07-24-2025
- Dividend Yield
- IRON N/A
- TCBK 3.31%
- EPS Growth
- IRON N/A
- TCBK 4.60
- EPS
- IRON N/A
- TCBK 3.43
- Revenue
- IRON N/A
- TCBK $389,795,000.00
- Revenue This Year
- IRON N/A
- TCBK $7.08
- Revenue Next Year
- IRON N/A
- TCBK $5.38
- P/E Ratio
- IRON N/A
- TCBK $11.63
- Revenue Growth
- IRON N/A
- TCBK 1.12
- 52 Week Low
- IRON $30.82
- TCBK $35.20
- 52 Week High
- IRON $68.73
- TCBK $51.06
- Technical
- Relative Strength Index (RSI)
- IRON 49.90
- TCBK 50.00
- Support Level
- IRON $44.85
- TCBK $39.51
- Resistance Level
- IRON $47.36
- TCBK $40.49
- Average True Range (ATR)
- IRON 2.23
- TCBK 0.82
- MACD
- IRON -0.12
- TCBK -0.12
- Stochastic Oscillator
- IRON 37.58
- TCBK 37.57
About IRON Disc Medicine Inc.
Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It aims to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for erythropoietic porphyrias (EPs) including erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF) and anemia of chronic kidney disease (CKD); and DISC-3405 for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, the Company's preclinical programs include DISC-0998.
About TCBK TriCo Bancshares
TriCo Bancshares is a California corporation organized to act as a bank holding company for Tri Counties Bank. The Bank is a California-chartered bank that is engaged in the general commercial and retail banking business in California counties. The Bank provides a breadth of personal, small business, and commercial financial services, including accepting demand, savings and time deposits and making small business, commercial, real estate, and consumer loans, as well as a range of treasury management services and other customary banking services including safe deposit boxes at some branches. The company's primary source of revenue is the net interest income.